A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00286806
Recruitment Status : Completed
First Posted : February 6, 2006
Last Update Posted : August 24, 2010
Information provided by:
Ascenta Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : June 2007
  Certification/Extension First Submitted : August 12, 2010